Announcements Trials

Browse Landscape

Sponsor

Conditions

Breast Neoplasms 38 Stomach Neoplasms 8 Neoplasm Metastasis 7 Colorectal Neoplasms 6 Neoplasms 5 HER2-positive Breast Cancer 5 Esophageal Neoplasms 5 Lung Neoplasms 4 Endometrial Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Rectal Neoplasms 3 Ovarian Neoplasms 3 Multiple Myeloma 3 Adenocarcinoma 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Salivary Gland Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Colonic Neoplasms 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Anatomic Stage II Breast Cancer AJCC v8 2 Anatomic Stage I Breast Cancer AJCC v8 2 Adenocarcinoma Of Esophagus 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1

Interventions

pembrolizumab 1 Pemetrexed 1 Control Groups 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Processes × Trastuzumab × 90 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡